CAS: 1326232-46-5 - Anifrolumab
Formula:Unspecified
- Synonyms:
- Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546 κ-chain, dimer
- MEDI 546
- Anifrolumab
- Immunoglobulin G1, anti-(human interferon α/β receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546 κ-chain, dimer
- Anifrolumab-fnia
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Anifrolumab REF: TM-T77432CAS: 1326232-46-5 | 95% - SDS-PAGE:95% SEC-HPLC:95% | 183.00 €~1,810.00 € | Thu 24 Oct 24 |
 | Anifrolumab REF: 3D-CLA1340CAS: 1326232-46-5 | - - - | To inquire | Tue 05 Nov 24 |
Anifrolumab
CAS:1326232-46-5
Anifrolumab(MEDI-546) is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that …
Purity:
95% - SDS-PAGE:95% SEC-HPLC:95%
Color and Shape:
Solid
Ref: TM-T77432
| 1mg | 183.00 € | ||
| 5mg | 416.00 € | ||
| 10mg | 641.00 € | ||
| 25mg | 1,000.00 € | ||
| 50mg | 1,355.00 € | ||
| 100mg | 1,810.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Anifrolumab
CAS:1326232-46-5
Monoclonal antibody targeting Interferon α/β receptor; used to treat systemic lupus erythematosus
Ref: 3D-CLA1340
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 5 Nov 2024
